GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Corona Remedies Ltd
Corona Remedies Ltd Recommends Final Dividend of ₹ 10/- Per Share for FY26
DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 11 May 2026, 06:22 PM IST  ·  BSE ID: e44067fe-74a8-479d-a4ec-db264304880b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has proposed a dividend of ₹ 10 per share for the last financial year.
🤖 AI Summary
  • Board recommended a final dividend of ₹ 10/- (100%) per equity share for FY 2025-26.
  • Record date for dividend entitlement is Friday, June 19, 2026.
  • Dividend payment, if approved by shareholders, is scheduled on or before August 07, 2026.
  • Board approved audited standalone and consolidated financial results for Q4 and year ended March 31, 2026.
  • Re-appointment of M/s. Walker Chandiok & Co LLP as Statutory Auditor also approved.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per equity share
₹ 10/-
Face value per equity share
₹ 10/-
🏢 How This Affects the Company
💰
Financial Impact
Declaration of dividend will result in an outflow of cash upon payment to shareholders. This will reduce the company's free cash reserves.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must hold shares in their demat account by the record date of Friday, June 19, 2026, to be eligible for the final dividend.
👤
Who Is Affected
Shareholders holding equity shares of Corona Remedies Ltd on Friday, June 19, 2026, will be entitled to receive ₹ 10/- per equity share.
🔍
Management Signal
The dividend recommendation and approval of auditors signal management's routine financial governance and capital allocation approach for the past fiscal year.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Annual General Meeting date — shareholders will vote on dividend and auditor appointments.
Dividend payment confirmation — verify payment by August 07, 2026.
FY 2025-26 Annual Report — review detailed financial performance.
LOW RISK The filing primarily consists of routine corporate actions, including a dividend recommendation.
💡 Investor Takeaway
Corona Remedies Ltd's Board recommended a final dividend of ₹ 10/- (100%) per equity share for FY 2025-26. The record date is June 19, 2026, with payment by August 07, 2026, subject to shareholder approval.
⚖️ Strengths & Concerns

✅ Positives

  • Recommendation of a final dividend indicates the company's board's view on its financial position for FY 2025-26.
  • Approval of audited financial results provides clarity on the company's financial performance up to March 31, 2026.
📅 Company Track Record
No previous filings found for Corona Remedies Ltd (BSE: 544644) within the provided context. This is the first disclosed corporate action related to a dividend.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.